Skip to search formSkip to main contentSkip to account menu

SKLB1002

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

QuinazolinesThiadiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cancer Therapy : Preclinical SKLB 1002 , a Novel Potent Inhibitor of VEGF Receptor 2 Signaling , Inhibits Angiogenesis and Tumor Growth In Vivo
Purpose: VEGF receptor 2 (VEGFR2) inhibitors, as efficient antiangiogenesis agents, have been applied in the cancer treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)